# LMED (Latamed Ai Corp.) - SEC EDGAR Financial Statements

> Latamed Ai Corp. reported $0 in revenue and a net loss of $316K for the trailing twelve months ended September 30, 2026.

- Canonical: https://convexityos.com/fundamentals/LMED
- Markdown: https://convexityos.com/fundamentals/LMED.md
- SEC CIK: 0001477960
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:51 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001477960&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Sep 30, 2026 |
| Operating Income | TTM | -$275K | Operating profit |
| Net Income | TTM | -$316K | GAAP bottom line |
| Diluted EPS | TTM | -$0.00 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 |
| Total Operating Expenses | $172K | $3.30M | $829K |
| **Operating Income** | -$172K | -$3.30M | -$829K |
| Interest Expense | $36K | $37K | $30K |
| Income Before Tax | -$207K | -$3.26M | -$1.73M |
| Income Tax Expense | $0 | $0 | $0 |
| **Net Income** | -$207K | -$3.26M | -$1.73M |
| **Diluted EPS** | -- | -$0.11 | -$0.02 |
| Diluted Shares Outstanding | -- | 29.3M | 88.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $46K | $77K | $43K | $108K | $28K | $20K | $16K | $982K |
| **Operating Income** | -$46K | -$77K | -$43K | -$108K | -$28K | -$20K | -$16K | -$982K |
| Interest Expense | -$13K | $10K | $9.4K | $29K | $8.4K | $9.3K | $8.5K | $9.0K |
| Income Before Tax | -$58K | -$87K | -$53K | -$118K | -$36K | -$29K | -$24K | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$58K | -$87K | -$53K | -$118K | -$36K | -$29K | -$24K | -$917K |
| Basic EPS | -- | $0.00 | -- | -- | -- | $0.00 | -- | -- |
| **Diluted EPS** | $0.00 | -- | -- | -- | $0.00 | -- | -- | -- |
| Diluted Shares Outstanding | 180.7M | 46.7M | -- | -- | 146.4M | 29.3M | -- | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Total Current Assets** | $0 | $0 | $0 |
| Intangible Assets | $0 | -- | -- |
| **Total Non-Current Assets** | $0 | $0 | $0 |
| **Total Assets** | $0 | $0 | $0 |
| **Total Current Liabilities** | $631K | $574K | $500K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 |
| **Total Liabilities** | $631K | $574K | $500K |
| Common Stock | $22K | $29K | $257 |
| Retained Earnings | -$29.60M | -$29.39M | -$26.13M |
| **Total Stockholders' Equity** | -$631K | -$574K | -$500K |
| Total Equity | -$631K | -$574K | -$500K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Total Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $7.82M | -- | -- | $0 | -- | -- | -- | -- |
| **Total Non-Current Assets** | $7.82M | $7.82M | $7.82M | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $7.82M | $7.82M | $7.82M | $0 | $0 | $0 | $0 | $0 |
| **Total Current Liabilities** | $829K | $771K | $684K | $631K | $664K | $627K | $598K | $574K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $829K | $771K | $684K | $631K | $664K | $627K | $598K | $574K |
| Common Stock | $18K | $36K | $56K | $22K | $29K | $29K | $29K | $29K |
| Retained Earnings | -$29.80M | -$29.74M | -$29.65M | -$29.60M | -$29.48M | -$29.45M | -$29.42M | -$29.39M |
| **Total Stockholders' Equity** | $6.99M | $7.05M | $7.14M | -$631K | -$664K | -$627K | -$598K | -$574K |
| Total Equity | $6.99M | $7.05M | $7.14M | -$631K | -$664K | -$627K | -$598K | -$574K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$207K | -$3.26M | -$1.73M |
| **Operating Cash Flow** | -$206K | -$67K | -$70K |
| Common Stock Issued | $150K | -- | -- |
| **Financing Cash Flow** | $206K | $67K | $70K |
| **Net Change in Cash** | $0 | $0 | $0 |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$58K | -$87K | -$53K | -$118K | -$36K | -$29K | -$24K | -$917K |
| **Operating Cash Flow** | -$34K | -$55K | -$28K | -$158K | -$14K | -$15K | -$19K | -$9.6K |
| **Financing Cash Flow** | $34K | $55K | $28K | $158K | $14K | $15K | $19K | $9.6K |
| **Net Change in Cash** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Current Ratio | 0.00x | 0.00x | 0.00x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -4.5% | -4.2% | -3.3% | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -4.0% | -3.8% | -3.0% | -- | -- | -- | -- | -- |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
